Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 20;8(4):e019967.
doi: 10.1136/bmjopen-2017-019967.

Incidence of superficial venous thrombosis in primary care and risk of subsequent venous thromboembolic sequelae: a retrospective cohort study performed with routine healthcare data from the Netherlands

Geert-Jan Geersing  1 , Selma Cazemier  1 , Frans Rutten  1 , David A Fitzmaurice  2 , Arno W Hoes  1
Affiliations

Incidence of superficial venous thrombosis in primary care and risk of subsequent venous thromboembolic sequelae: a retrospective cohort study performed with routine healthcare data from the Netherlands

Geert-Jan Geersing et al. BMJ Open. .

Abstract

Objectives: Recent studies in referred populations of patients with superficial venous thrombosis (SVT) report risks of venous thromboembolic (VTE) sequelae (deep vein thrombosis or pulmonary embolism) as high as 25%. Likely, these estimates are lower in non-referred patients, but large-scale population-based studies are lacking. We aimed to estimate the incidence rate of SVT in primary care and quantify its risk of VTE sequelae.

Design: A retrospective cohort study, using International Classification of Primary Care coding (K94.02) combined with free text searching (synonyms for SVT) to capture all SVT events. All patients were followed up for 3 months using manual free text searching.

Setting: Primary care.

Participants: All patients enlisted with general practitioners within the Utrecht General Practitioner Network between 2010 and 2016 (1 534 845 person-years follow-up).

Main outcome measures: The incidence rate of SVT was expressed as the number of SVT events per 1000 person-years of follow-up and the 3-month cumulative incidence of VTE events was calculated. Logistic regression analysis was used to compare patients with SVT with and without VTE sequelae.

Results: A total of 2008 SVT cases were identified, that is, an SVT incidence rate of 1.31 (95% CI 1.25 to 1.37) per 1000 person-years follow-up, with higher rates notably with increasing age. VTE sequelae occurred in 83 patients; 51 at the time of SVT diagnosis and 32 patients during follow-up (total cumulative incidence of 4.1%; 95% CI 3.3% to 5.1%), and were more frequent in those with an active malignancy (OR 2.19; 95% 0.97 to 4.95) and less frequent in those with varicose veins at baseline (OR 0.57, 95% CI 0.34 to 0.94).

Conclusion: We found an incidence rate of SVT in primary care of 1.31 per 1000 person-years. The risks of VTE sequelae was relatively low at 4.1%, with the highest risk in patients with cancer and in those who experience an SVT in the absence of varicose veins.

Keywords: anticoagulation; primary care; thromboembolism.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flow chart of included patients. DVT, deep vein thrombosis; PE, pulmonary embolism; SVT, superficial venous thrombosis; VTE, venous thromboembolism.
Figure 2
Figure 2
Incidence rate of superficial venous thrombosis according to age. IR, incidence rate.
See this image and copyright information in PMC

References

    1. Di Minno MN, Ambrosino P, Ambrosini F, et al. . Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis. J Thromb Haemost 2016;14:964–72. 10.1111/jth.13279 - DOI - PubMed
    1. Decousus H, Quéré I Presles E, et al. . Superficial venous thrombosis and venous thromboembolism. Ann Intern Med 2010;152:218. - PubMed
    1. Leon L, Giannoukas AD, Dodd D, et al. . Clinical significance of superficial vein thrombosis. Eur J Vasc Endovasc Surg 2005;29:10–17. 10.1016/j.ejvs.2004.09.021 - DOI - PubMed
    1. Quenet S, Laporte S, Décousus H, et al. . Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis. J Vasc Surg 2003;38:944–9. 10.1016/S0741-5214(03)00607-4 - DOI - PubMed
    1. Beyer-Westendorf J, Schellong SM, Gerlach H, et al. . Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial. Lancet Haematol 2017;4:e105–e113. 10.1016/S2352-3026(17)30014-5 - DOI - PubMed

Publication types